Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Long-Term Debt Repayments (2016 - 2018)

Wave Life Sciences' Long-Term Debt Repayments history spans 4 years, with the latest figure at $16000.0 for Q1 2018.

  • For Q1 2018, Long-Term Debt Repayments changed 0.0% year-over-year to $16000.0; the TTM value through Dec 2018 reached $16000.0, down 74.19%, while the annual FY2018 figure was $16000.0, 74.19% down from the prior year.
  • Long-Term Debt Repayments reached $16000.0 in Q1 2018 per WVE's latest filing, up from $15000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $16000.0 in Q1 2016 to a low of $14000.0 in Q4 2015.
  • Average Long-Term Debt Repayments over 4 years is $15363.6, with a median of $15000.0 recorded in 2015.
  • Peak YoY movement for Long-Term Debt Repayments: rose 7.14% in 2016, then changed 0.0% in 2017.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $14000.0 in 2015, then grew by 7.14% to $15000.0 in 2016, then changed by 0.0% to $15000.0 in 2017, then grew by 6.67% to $16000.0 in 2018.
  • Per Business Quant, the three most recent readings for WVE's Long-Term Debt Repayments are $16000.0 (Q1 2018), $15000.0 (Q4 2017), and $16000.0 (Q3 2017).